Publications by authors named "Markus K Muellner"

15Publications

Light-assisted small-molecule screening against protein kinases.

Nat Chem Biol 2015 Dec 12;11(12):952-4. Epub 2015 Oct 12.

Institute of Science and Technology Austria (IST Austria), Klosterneuburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.1933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652335PMC
December 2015

p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.

Hepatology 2011 Jul;54(1):164-72

Department of Medicine I, Division: Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24329DOI Listing
July 2011

Giving Rho(d) directions.

Nat Chem Biol 2010 Jun;6(6):397-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.373DOI Listing
June 2010

Vitamin C inhibits NO-induced stabilization of HIF-1alpha in HUVECs.

Free Radic Res 2010 Jul;44(7):783-91

Center of Pathobiochemistry and Genetics, Department of Medical Chemistry, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10715761003786172DOI Listing
July 2010

Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE.

Neurotox Res 2010 Apr 13;17(3):249-56. Epub 2009 Aug 13.

Department of Medical Chemistry, Medical University Vienna, Waehringerstr. 10, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12640-009-9099-9DOI Listing
April 2010

The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.

J Hypertens 2007 Oct;25(10):2100-4

Centre of Physiology and Pathophysiology, Department of Medical Chemistry, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0b013e32829b8fd0DOI Listing
October 2007

Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.

Free Radic Res 2007 Jul;41(7):741-7

Department of Medical Chemistry, Centre of Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10715760701263265DOI Listing
July 2007